Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

Parkinson DiseaseMild Cognitive Impairment

Interventions

DRUG

Donepezil Hydrochloride

Donepezil 10mg once daily

DRUG

Placebo

Matching placebo

All Listed Sponsors

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER